Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.

  • Authors:
    • Y J Chen
    • L S Shih
    • Y M Chen
  • View Affiliations

  • Published online on: August 1, 1998     https://doi.org/10.3892/ijo.13.2.249
  • Pages: 249-303
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The mRNA level of CDKN2 (p16), retinoblastoma (Rb) and p53 in cancerous and non-cancerous tissue samples were compared using a semi-quantitative reverse-transcription-polymerase chain reaction method. The mean CDKN2 mRNA level of 10 gastric cancer specimens was significantly higher than that of their non-cancerous tissue samples (p=0.039). In contrast, the mRNA levels of Rb and p53 in gastric cancer tissues were both significantly lower than those in their non-cancerous tissue samples. Furthermore, both mRNA ratios of Rb/CDKN2 and p53/CDKN2 were significantly decreased in gastric cancer tissues. Therefore, suppression of both Rb and p53 and overexpression of CDKN2 may be associated with the tumorigenesis of gastric cancer.

Related Articles

Journal Cover

Aug 1998
Volume 13 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Shih L and Chen Y: Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.. Int J Oncol 13: 249-303, 1998
APA
Chen, Y., Shih, L., & Chen, Y. (1998). Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.. International Journal of Oncology, 13, 249-303. https://doi.org/10.3892/ijo.13.2.249
MLA
Chen, Y., Shih, L., Chen, Y."Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.". International Journal of Oncology 13.2 (1998): 249-303.
Chicago
Chen, Y., Shih, L., Chen, Y."Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma.". International Journal of Oncology 13, no. 2 (1998): 249-303. https://doi.org/10.3892/ijo.13.2.249